|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
(+ 0 more)
487 a.a.
|
 |
|
|
|
|
|
|
|
(+ 0 more)
467 a.a.
|
 |
|
|
|
|
|
|
|
167 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
The structure of f1-atpase inhibited by quercetin.
|
|
Structure:
|
 |
Atp synthase subunit alpha heart isoform. Chain: a, b, c, h, i, j. Fragment: residues 44-553. Synonym: atp synthase alpha chain heart isoform. Atp synthase subunit beta. Chain: d, e, f, k, l, m. Fragment: residues 47-528. Synonym: atp synthase beta chain. Atp synthase gamma chain.
|
|
Source:
|
 |
Bos taurus. Bovine. Organism_taxid: 9913. Organ: heart. Organ: heart
|
|
Resolution:
|
 |
|
2.40Å
|
R-factor:
|
0.190
|
R-free:
|
0.238
|
|
|
Authors:
|
 |
J.R.Gledhill,M.G.Montgomery,A.G.W.Leslie,J.E.Walker
|
Key ref:
|
 |
J.R.Gledhill
et al.
(2007).
Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols.
Proc Natl Acad Sci U S A,
104,
13632-13637.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
03-Jul-07
|
Release date:
|
21-Aug-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P19483
(ATPA_BOVIN) -
ATP synthase subunit alpha, mitochondrial from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
553 a.a.
487 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains D, E, F, K, L, M:
E.C.7.1.2.2
- H(+)-transporting two-sector ATPase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + H2O + 4 H+(in) = ADP + phosphate + 5 H+(out)
|
 |
 |
 |
 |
 |
ATP
|
+
|
H2O
|
+
|
4
×
H(+)(in)
|
=
|
ADP
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
phosphate
|
+
|
5
×
H(+)(out)
Bound ligand (Het Group name = )
corresponds exactly
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
104:13632-13637
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols.
|
|
J.R.Gledhill,
M.G.Montgomery,
A.G.Leslie,
J.E.Walker.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structures of F(1)-ATPase from bovine heart mitochondria inhibited with the
dietary phytopolyphenol, resveratrol, and with the related polyphenols quercetin
and piceatannol have been determined at 2.3-, 2.4- and 2.7-A resolution,
respectively. The inhibitors bind to a common site in the inside surface of an
annulus made from loops in the three alpha- and three beta-subunits beneath the
"crown" of beta-strands in their N-terminal domains. This region of
F(1)-ATPase forms a bearing to allow the rotation of the tip of the
gamma-subunit inside the annulus during catalysis. The binding site is a
hydrophobic pocket between the C-terminal tip of the gamma-subunit and the
beta(TP) subunit, and the inhibitors are bound via H-bonds mostly to their
hydroxyl moieties mediated by bound water molecules and by hydrophobic
interactions. There are no equivalent sites between the gamma-subunit and either
the beta(DP) or the beta(E) subunit. The inhibitors probably prevent both the
synthetic and hydrolytic activities of the enzyme by blocking both senses of
rotation of the gamma-subunit. The beneficial effects of dietary resveratrol may
derive in part by preventing mitochondrial ATP synthesis in tumor cells, thereby
inducing apoptosis.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Structures of polyphenol inhibitors of bovine
F[1]-ATPase. (I) Resveratrol. (II) Piceatannol. (III) Quercetin.
|
 |
Figure 3.
Fig. 3. Comparison of the modes of binding to bovine
F[1]-ATPase of piceatannol and quercetin with that of
resveratrol. (A) Major binding modes of resveratrol (green) and
piceatannol (gray). (B) Major binding mode of resveratrol
(green) and cis-quercetin (gray).
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Beauloye,
L.Bertrand,
S.Horman,
and
L.Hue
(2011).
AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure.
|
| |
Cardiovasc Res,
90,
224-233.
|
 |
|
|
|
|
 |
D.G.Hardie
(2011).
AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer.
|
| |
Biochem Soc Trans,
39,
1.
|
 |
|
|
|
|
 |
K.Okazaki,
and
S.Takada
(2011).
Structural Comparison of F(1)-ATPase: Interplay among Enzyme Structures, Catalysis, and Rotations.
|
| |
Structure,
19,
588-598.
|
 |
|
|
|
|
 |
A.C.Stelzer,
R.W.Frazee,
C.Van Huis,
J.Cleary,
A.W.Opipari,
G.D.Glick,
and
H.M.Al-Hashimi
(2010).
NMR studies of an immunomodulatory benzodiazepine binding to its molecular target on the mitochondrial F(1)F(0)-ATPase.
|
| |
Biopolymers,
93,
85-92.
|
 |
|
|
|
|
 |
D.Herranz,
and
M.Serrano
(2010).
SIRT1: recent lessons from mouse models.
|
| |
Nat Rev Cancer,
10,
819-823.
|
 |
|
|
|
|
 |
H.M.Eid,
L.C.Martineau,
A.Saleem,
A.Muhammad,
D.Vallerand,
A.Benhaddou-Andaloussi,
L.Nistor,
A.Afshar,
J.T.Arnason,
and
P.S.Haddad
(2010).
Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea.
|
| |
Mol Nutr Food Res,
54,
991.
|
 |
|
|
|
|
 |
L.Mouchiroud,
L.Molin,
N.Dallière,
and
F.Solari
(2010).
Life span extension by resveratrol, rapamycin, and metformin: The promise of dietary restriction mimetics for an healthy aging.
|
| |
Biofactors,
36,
377-382.
|
 |
|
|
|
|
 |
L.Notari,
N.Arakaki,
D.Mueller,
S.Meier,
J.Amaral,
and
S.P.Becerra
(2010).
Pigment epithelium-derived factor binds to cell-surface F(1)-ATP synthase.
|
| |
FEBS J,
277,
2192-2205.
|
 |
|
|
|
|
 |
M.D.Fullerton,
and
G.R.Steinberg
(2010).
SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol.
|
| |
Diabetes,
59,
551-553.
|
 |
|
|
|
|
 |
S.A.Hawley,
F.A.Ross,
C.Chevtzoff,
K.A.Green,
A.Evans,
S.Fogarty,
M.C.Towler,
L.J.Brown,
O.A.Ogunbayo,
A.M.Evans,
and
D.G.Hardie
(2010).
Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation.
|
| |
Cell Metab,
11,
554-565.
|
 |
|
|
|
|
 |
S.Fulda,
L.Galluzzi,
and
G.Kroemer
(2010).
Targeting mitochondria for cancer therapy.
|
| |
Nat Rev Drug Discov,
9,
447-464.
|
 |
|
|
|
|
 |
S.J.Ralph,
S.Rodríguez-Enríquez,
J.Neuzil,
E.Saavedra,
and
R.Moreno-Sánchez
(2010).
The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
|
| |
Mol Aspects Med,
31,
145-170.
|
 |
|
|
|
|
 |
T.F.Laughlin,
and
Z.Ahmad
(2010).
Inhibition of Escherichia coli ATP synthase by amphibian antimicrobial peptides.
|
| |
Int J Biol Macromol,
46,
367-374.
|
 |
|
|
|
|
 |
J.Bernatoniene,
S.Trumbeckaite,
D.Majiene,
R.Baniene,
G.Baliutyte,
A.Savickas,
and
A.Toleikis
(2009).
The effect of crataegus fruit extract and some of its flavonoids on mitochondrial oxidative phosphorylation in the heart.
|
| |
Phytother Res,
23,
1701-1707.
|
 |
|
|
|
|
 |
L.S.Chen,
B.J.Nowak,
M.L.Ayres,
N.L.Krett,
S.T.Rosen,
S.Zhang,
and
V.Gandhi
(2009).
Inhibition of ATP synthase by chlorinated adenosine analogue.
|
| |
Biochem Pharmacol,
78,
583-591.
|
 |
|
|
|
|
 |
M.Vollmar,
D.Schlieper,
M.Winn,
C.Büchner,
and
G.Groth
(2009).
Structure of the c14 rotor ring of the proton translocating chloroplast ATP synthase.
|
| |
J Biol Chem,
284,
18228-18235.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Pervaiz,
and
A.L.Holme
(2009).
Resveratrol: its biologic targets and functional activity.
|
| |
Antioxid Redox Signal,
11,
2851-2897.
|
 |
|
|
|
|
 |
A.Mattarei,
L.Biasutto,
E.Marotta,
U.De Marchi,
N.Sassi,
S.Garbisa,
M.Zoratti,
and
C.Paradisi
(2008).
A mitochondriotropic derivative of quercetin: a strategy to increase the effectiveness of polyphenols.
|
| |
Chembiochem,
9,
2633-2642.
|
 |
|
|
|
|
 |
K.T.Howitz,
and
D.A.Sinclair
(2008).
Xenohormesis: sensing the chemical cues of other species.
|
| |
Cell,
133,
387-391.
|
 |
|
|
|
|
 |
L.Potenza,
C.Calcabrini,
R.De Bellis,
U.Mancini,
L.Cucchiarini,
and
M.Dachà
(2008).
Effect of quercetin on oxidative nuclear and mitochondrial DNA damage.
|
| |
Biofactors,
33,
33-48.
|
 |
|
|
|
|
 |
P.L.Toogood
(2008).
Mitochondrial drugs.
|
| |
Curr Opin Chem Biol,
12,
457-463.
|
 |
|
|
|
|
 |
S.Hong,
and
P.L.Pedersen
(2008).
ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.
|
| |
Microbiol Mol Biol Rev,
72,
590.
|
 |
|
|
|
|
 |
J.R.Gledhill,
M.G.Montgomery,
A.G.Leslie,
and
J.E.Walker
(2007).
How the regulatory protein, IF(1), inhibits F(1)-ATPase from bovine mitochondria.
|
| |
Proc Natl Acad Sci U S A,
104,
15671-15676.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |
|